WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine reviews scientific evidence on the relationship between moderate alcohol consumption and health outcomes.
Despite $2.5 million placeholder price tags, the Institute for Clinical and Economic Review draft evidence report considers gene therapy cost-effective versus comparators in both hemophilia A and B.